It showed that a CEA level greater than 200 ng/mL and a CA72.4 level over 40 U/mL both had less than 50% sensitivity for establishing IPMN diagnoses. The gene discussed is CEACAM5; the disease is pancreatic intraductal papillary-mucinous neoplasm.